{"log_id": 4235595956166958463, "direction": 0, "words_result_num": 51, "words_result": [{"probability": {"variance": 9e-06, "average": 0.997942, "min": 0.985759}, "location": {"width": 991, "top": 105, "height": 27, "left": 109}, "words": "酮和雌二醇)主要由外周组织中的芳香酶将肾上腺和卵巢中的雄激素(雄烯二酮和睾酮)转化而来。通过抑"}, {"probability": {"variance": 1.3e-05, "average": 0.998163, "min": 0.980651}, "location": {"width": 991, "top": 135, "height": 25, "left": 109}, "words": "制芳香酶来阻止雌激素生成是一种有效的选择性治疗绝经后激素依赖性乳腺癌的方法。依西美坦为一种不可"}, {"probability": {"variance": 4e-06, "average": 0.999039, "min": 0.989942}, "location": {"width": 991, "top": 164, "height": 25, "left": 110}, "words": "逆性甾体芳香酶灭活剂,结构上与该酶的自然底物雄烯二酮相似,为芳香酶的伪底物,可通过不可逆地与该"}, {"probability": {"variance": 0.000543, "average": 0.995034, "min": 0.836162}, "location": {"width": 990, "top": 193, "height": 27, "left": 110}, "words": "酶的活性位点结合而使其失活(该作用也称“自毁性抑制”),从而明显降低绝经妇女血液循环中的雌激素水"}, {"probability": {"variance": 4e-06, "average": 0.998665, "min": 0.989994}, "location": {"width": 991, "top": 223, "height": 26, "left": 109}, "words": "平,但对肾上腺中皮质类固醇和醛固醇的生物合成无明显影响。在高于抑制芳香酶作用浓度的600倍时,对"}, {"probability": {"variance": 1e-06, "average": 0.999039, "min": 0.99519}, "location": {"width": 403, "top": 252, "height": 26, "left": 109}, "words": "类固醇生成途径中的其他酶不产生明显影响"}, {"probability": {"variance": 0, "average": 0.999215, "min": 0.998494}, "location": {"width": 87, "top": 283, "height": 24, "left": 151}, "words": "毒理研究"}, {"probability": {"variance": 0.000545, "average": 0.992953, "min": 0.841277}, "location": {"width": 941, "top": 311, "height": 27, "left": 150}, "words": "单次给药毒性:小鼠单次经口给药剂量达3200mg/kg(按体表面积计算,约为人临床推荐剂量的640倍"}, {"probability": {"variance": 5.4e-05, "average": 0.996516, "min": 0.965446}, "location": {"width": 991, "top": 342, "height": 26, "left": 108}, "words": "时,出现死亡。大鼠和犬单次剂量分别为5000mg/kg和3000mg/kg(按体表面积计算,分别约为人临床推"}, {"probability": {"variance": 5.5e-05, "average": 0.996404, "min": 0.954032}, "location": {"width": 987, "top": 371, "height": 27, "left": 109}, "words": "荐剂量的2000倍和4000倍)时,动物出现死亡。小鼠和犬单次给药剂量分别达400mg/kg和3000mg/kg(按"}, {"probability": {"variance": 0.000241, "average": 0.995952, "min": 0.905626}, "location": {"width": 739, "top": 401, "height": 26, "left": 108}, "words": "体表面积计算,分别约为人临床推荐剂量的80倍和4000倍)时,动物出现惊厥"}, {"probability": {"variance": 1.8e-05, "average": 0.99808, "min": 0.974179}, "location": {"width": 949, "top": 430, "height": 26, "left": 151}, "words": "临床研究中,健康人本品单次给药剂量达800mg/kg及晚期乳腺癌患者剂量高达600mg/kg连续给药12"}, {"probability": {"variance": 1e-06, "average": 0.999339, "min": 0.997262}, "location": {"width": 275, "top": 460, "height": 24, "left": 109}, "words": "周时,均表现出良好的耐受性"}, {"probability": {"variance": 5.9e-05, "average": 0.996775, "min": 0.949174}, "location": {"width": 934, "top": 487, "height": 27, "left": 150}, "words": "生殖毒性:交配前14天至妊娠15-20天内,大鼠给予本品,泌乳期继续给药21天,其剂量为4mg/kg"}, {"probability": {"variance": 6.7e-05, "average": 0.997623, "min": 0.941334}, "location": {"width": 975, "top": 517, "height": 26, "left": 110}, "words": "日(按体表面积计算,相当于人临床推荐剂量的1.5倍)时,出现胎盘重量增加;剂量大于或等于20mg/kg"}, {"probability": {"variance": 0.00566, "average": 0.98609, "min": 0.477223}, "location": {"width": 989, "top": 546, "height": 27, "left": 110}, "words": "日时,出现妊娠期延长、分娩异常或困难。同时也观察到吸收胎增加、活胎数减少、胎仔重量降低、骨化延"}, {"probability": {"variance": 7e-06, "average": 0.997961, "min": 0.987902}, "location": {"width": 983, "top": 575, "height": 27, "left": 107}, "words": "迟。妊娠大鼠器官形成期给药剂量小于或等于810mg/kg(按体表面积计算,约为人临床推荐剂量的320倍"}, {"probability": {"variance": 5e-06, "average": 0.998308, "min": 0.988239}, "location": {"width": 993, "top": 603, "height": 28, "left": 107}, "words": "时,未出现明显致畸胎作用。家兔器官形成期给药剂量90mg/kg/日(按体表面积计算,约为推荐人临床用"}, {"probability": {"variance": 0.000314, "average": 0.996281, "min": 0.870372}, "location": {"width": 992, "top": 631, "height": 27, "left": 107}, "words": "剂量的70倍)时,出现胎盘重量降低;剂量为270mg/kg/日时,出现流产、吸收胎增加和胎兔体重降低;剂"}, {"probability": {"variance": 4.4e-05, "average": 0.997116, "min": 0.963819}, "location": {"width": 982, "top": 660, "height": 28, "left": 108}, "words": "量小于或等于270mg/kg/日(按体表面积计算,约为人临床推荐剂量的210倍)时,家兔畸形率未见增加"}, {"probability": {"variance": 1.4e-05, "average": 0.998261, "min": 0.978625}, "location": {"width": 990, "top": 691, "height": 26, "left": 109}, "words": "目前尚无本品对孕妇影响的临床研究资料,若妊娠期服用本品,应告之患者本品对胎儿的潜在危害性和出现"}, {"probability": {"variance": 2e-06, "average": 0.998426, "min": 0.995245}, "location": {"width": 149, "top": 721, "height": 25, "left": 108}, "words": "流产的潜在危险"}, {"probability": {"variance": 5.1e-05, "average": 0.997305, "min": 0.94952}, "location": {"width": 950, "top": 749, "height": 26, "left": 151}, "words": "交配前63天及合笼期间,雄性大鼠给药500mg/kg/日(按体表面积计算,约为人临床推荐量的200倍)"}, {"probability": {"variance": 4.5e-05, "average": 0.997153, "min": 0.964788}, "location": {"width": 990, "top": 778, "height": 27, "left": 108}, "words": "时,可使与之交配的未给药雌性大鼠的生育力降低。本品剂量为20mg/kg/日(按体表面积计算,相当于人"}, {"probability": {"variance": 1e-06, "average": 0.999334, "min": 0.995501}, "location": {"width": 990, "top": 807, "height": 27, "left": 109}, "words": "临床推荐剂量的8倍)时,对雌性大鼠生育力参数(如卵巢功能、交配行为、受孕率)无影响,但使平均窝"}, {"probability": {"variance": 0.002906, "average": 0.988908, "min": 0.624011}, "location": {"width": 993, "top": 835, "height": 27, "left": 106}, "words": "仔数降低。另外,在一般毒性研究中,按体表面积计算,给药量为人临床推荐剂量的3-20倍时,小鼠、大"}, {"probability": {"variance": 4e-06, "average": 0.998545, "min": 0.991561}, "location": {"width": 762, "top": 866, "height": 27, "left": 108}, "words": "鼠及犬均不同程度地出现卵巢改变包括过度增生卵巢囊肿数增多及黄体数减少"}, {"probability": {"variance": 0.009518, "average": 0.969352, "min": 0.513353}, "location": {"width": 949, "top": 893, "height": 27, "left": 150}, "words": "大鼠经口给予放射标记的14c人依西美坦1mg/kg后,发现其可通过胎盘,给药后15分钟在乳汁中出现"}, {"probability": {"variance": 5.3e-05, "average": 0.997822, "min": 0.950757}, "location": {"width": 983, "top": 922, "height": 28, "left": 107}, "words": "带放射活性的依西美坦,上述剂量下单次给药后24小时,本品及其代谢物在母体与胎儿血液中的浓度相当"}, {"probability": {"variance": 0.000121, "average": 0.996641, "min": 0.931458}, "location": {"width": 806, "top": 951, "height": 28, "left": 108}, "words": "尚不知本品是否通过人乳汁分泌。因许多药物可经乳汁分泌,故哺乳期妇女应慎用本品"}, {"probability": {"variance": 0.00118, "average": 0.987081, "min": 0.847527}, "location": {"width": 949, "top": 980, "height": 29, "left": 149}, "words": "遗传毒性:本品在Ames试验和V79中国仓鼠肺细胞试验中未表现出致突变作用。在体外无代谢活化的情况"}, {"probability": {"variance": 0.000932, "average": 0.993454, "min": 0.790611}, "location": {"width": 968, "top": 1008, "height": 29, "left": 109}, "words": "下,对人淋巴细胞表现出致突变作用但小鼠微核试验结果阴性。本品不增加大鼠肝细胞的程序外DNA合成"}, {"probability": {"variance": 4e-06, "average": 0.998017, "min": 0.993733}, "location": {"width": 298, "top": 1038, "height": 27, "left": 148}, "words": "致癌性:目前尚无本品致癌作用"}, {"probability": {"variance": 2.1e-05, "average": 0.997334, "min": 0.980766}, "location": {"width": 947, "top": 1067, "height": 27, "left": 151}, "words": "[药代动力学]据文献报告,绝经的健康女性口服放射标记的依西美坦后,吸收迅速,至少42%的依西"}, {"probability": {"variance": 0.001285, "average": 0.993082, "min": 0.750385}, "location": {"width": 991, "top": 1096, "height": 28, "left": 108}, "words": "美坦在胃肠道被吸收:食用高脂肪餐后;其血浆水平上升约40%。依西美坦在各组织中广泛分布,其血浆蛋"}, {"probability": {"variance": 0.01071, "average": 0.974125, "min": 0.488765}, "location": {"width": 991, "top": 1125, "height": 27, "left": 108}, "words": "白结合率为90%。依西美坦的代谢率广泛,主要通过6-位亚甲基的氧化和17-位酮基还原进行代谢,代谢"}, {"probability": {"variance": 1.5e-05, "average": 0.998302, "min": 0.973269}, "location": {"width": 992, "top": 1155, "height": 27, "left": 107}, "words": "产物无活性或抑制芳香酶活性较弱,其代谢物主要从尿和粪中排泄,约各占40%左右、尿中排出的原形药物"}, {"probability": {"variance": 0.001764, "average": 0.990396, "min": 0.710295}, "location": {"width": 982, "top": 1184, "height": 27, "left": 107}, "words": "低于给药量的1%。依西美坦的平均终末半衰期为24小时。乳腺癌晚期绝经后女性的吸收较健康绝经女性快"}, {"probability": {"variance": 0.000103, "average": 0.996333, "min": 0.947369}, "location": {"width": 983, "top": 1213, "height": 27, "left": 107}, "words": "达峰时间分别为1.2小时和2.9小时。重复给药后,乳腺癌晚期患者的平均口服清除率较健康绝经女性低45%"}, {"probability": {"variance": 3e-06, "average": 0.999086, "min": 0.993883}, "location": {"width": 523, "top": 1243, "height": 26, "left": 107}, "words": "而循环中的水平较高:其平均AUC较健康女性高约2倍"}, {"probability": {"variance": 6e-06, "average": 0.998594, "min": 0.987327}, "location": {"width": 715, "top": 1271, "height": 27, "left": 150}, "words": "中或重度肝肾功能不全者,单次口服依西美坦后的AUC较健康志愿者高3倍"}, {"probability": {"variance": 4.9e-05, "average": 0.995888, "min": 0.97646}, "location": {"width": 221, "top": 1301, "height": 25, "left": 153}, "words": "贮藏]遮光,密封保存"}, {"probability": {"variance": 2.3e-05, "average": 0.996989, "min": 0.98515}, "location": {"width": 267, "top": 1331, "height": 25, "left": 154}, "words": "包装]铝塑包装,14片/板"}, {"probability": {"variance": 0.000423, "average": 0.989902, "min": 0.936028}, "location": {"width": 160, "top": 1360, "height": 25, "left": 154}, "words": "有效期]24个月"}, {"probability": {"variance": 0.007139, "average": 0.950645, "min": 0.644086}, "location": {"width": 318, "top": 1389, "height": 25, "left": 153}, "words": "[执行标准]WS1-(X-010)-2006Z"}, {"probability": {"variance": 0.000418, "average": 0.983239, "min": 0.918963}, "location": {"width": 308, "top": 1416, "height": 28, "left": 152}, "words": "[批准文号]国药准字H200002"}, {"probability": {"variance": 0.02237, "average": 0.913322, "min": 0.497742}, "location": {"width": 484, "top": 1464, "height": 54, "left": 276}, "words": "龙限心齐鲁制药有限公司"}, {"probability": {"variance": 0.019558, "average": 0.912072, "min": 0.427923}, "location": {"width": 755, "top": 1512, "height": 36, "left": 128}, "words": "生产地址:山东省济南市业北路243号电话:(531)832888传真"}, {"probability": {"variance": 7e-06, "average": 0.996899, "min": 0.990656}, "location": {"width": 116, "top": 1522, "height": 22, "left": 960}, "words": ")83126688"}, {"probability": {"variance": 0.001975, "average": 0.97755, "min": 0.847053}, "location": {"width": 180, "top": 1548, "height": 31, "left": 127}, "words": "邮政编码250100"}, {"probability": {"variance": 0.009294, "average": 0.953159, "min": 0.621735}, "location": {"width": 187, "top": 1551, "height": 27, "left": 448}, "words": "网址:www.qilu-ph"}], "language": 3}